Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    canary
Show Display Options
Rank Status Study
1 Unknown  Using the Canary Breathing System for Panic Disorder Patients
Condition: Panic Disorder
Intervention: Device: Canary Breathing System
2 Terminated CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
Conditions: Coronary Atherosclerosis;   Myocardial Infarction;   Coronary Plaque Embolization
Interventions: Device: Embolic Protection Device (EPD);   Device: Intracoronary Spectroscopy and Ultrasonic Evaluation;   Device: Angioplasty and Stent Implant
3 Recruiting Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Condition: Sepsis
Intervention: Device: Isomark Canary™
4 Recruiting Changes in 13CO2/12CO2 Delta Value in Exhaled Breath as an Early Indicator of Infection in Adult Trauma Subjects
Condition: Sepsis
Intervention: Device: Isomark Canary™
5 Not yet recruiting Using Exhaled Air to Determine Changes in Nutritional Status of Patients on Intravenous Nutrition
Conditions: Obesity;   Malnourished;   Fasting
Intervention: Device: Isomark Canary
6 Completed
Has Results
Accelerated Immunization to Induce Cytomegalovirus Immunity in Stem Cell Donors
Condition: Cytomegalovirus Infections
Intervention: Biological: ALVAC-CMV (vCP260)
7 Active, not recruiting Tertiary Prevention in Type II Diabetes Mellitus in Canary Islands Study
Condition: Type 2 Diabetes Mellitus
Interventions: Behavioral: Intervention to patients;   Behavioral: Intervention to professionals;   Other: Usual care
8 Recruiting The Mobile Monitoring of Vital Signs in Opioid Users
Condition: Opioid Use Disorders
Intervention: Device: Canary 01 Mobile Vital Signs Monitoring Device
9 Recruiting Prostate Active Surveillance Study
Condition: Prostatic Neoplasms
10 Completed A Critical Appraisal of the Role of Near Infrared Spectroscopy (NIRS) in the Pediatric Intensive Care Unit (PICU)
Condition: Pediatric Intensive Care Unit
11 Completed Safety and Efficacy of Intravenous Tranexamic Acid in Endoscopic Transurethral Resections in Urology
Condition: Hemorrhage
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
12 Completed Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients
Condition: HIV Infection
Interventions: Biological: one injection of vCP1452 at W0, W4, W8 and W20;   Biological: one injection of vCP1452 at W4, W8 and W20;   Biological: one injection of placebo at W0, W4, W8, W20 or at W4, W8,W20
13 Recruiting Incidence of Type 2 Diabetes in the Study
Conditions: Diabetes Mellitus, Type 2;   Metabolic Syndrome X
14 Terminated
Has Results
Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma
Conditions: Metastatic Melanoma;   Skin Cancer
Interventions: Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Biological: Aldesleukin;   Biological: ALVAC gp100 Vaccine;   Biological: anti-gp100:154-162 Tcell receptor (TCR) peripheral blood lymphocyte (PBL)
15 Terminated
Has Results
Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma
Conditions: Metastatic Melanoma;   Skin Cancer
Interventions: Biological: autologous anti-MART-1 F5 T-cell receptor gene-engineered peripheral blood lymphocytes;   Biological: ALVAC MART-1 Vaccine;   Biological: aldesleukin;   Drug: cyclophosphamide;   Drug: fludarabine phosphate
16 Withdrawn Strategies for Improving Proton Pump Inhibitors (PPIs) Prescription Associated to Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Condition: Adverse Events
Interventions: Behavioral: Group education, audit-feedback and computer support;   Behavioral: Audit-feedback and computer support;   Behavioral: Control
17 Completed Effect of Curodont Repair or Placebo on the Remineralisation in Patients With Class 5 Carious Lesions
Condition: Dental Caries
Interventions: Device: Curodont Repair;   Other: Placebo;   Device: Fluoride
18 Active, not recruiting Getting in Balance: A Workplace Diabetes Prevention Intervention Trial
Conditions: Diabetes Mellitus, Type 2;   Overweight;   Obesity
Interventions: Behavioral: In-Person Diabetes Prevention Program;   Behavioral: Online Diabetes Prevention Program
19 Completed Air Pollution, Inflammation and Acute Coronary Syndrome
Condition: Patients With Acute Coronary Syndrome
Intervention: Other: Particulate air pollutants
20 Unknown  Biological Half Life of DLBS1033 in Healthy Volunteers
Condition: Healthy Condition
Intervention: Drug: DLBS1033

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Indicates status has not been verified in more than two years